Correlation Between Evogene and Gamida Cell
Can any of the company-specific risk be diversified away by investing in both Evogene and Gamida Cell at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Evogene and Gamida Cell into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Evogene and Gamida Cell, you can compare the effects of market volatilities on Evogene and Gamida Cell and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Evogene with a short position of Gamida Cell. Check out your portfolio center. Please also check ongoing floating volatility patterns of Evogene and Gamida Cell.
Diversification Opportunities for Evogene and Gamida Cell
0.17 | Correlation Coefficient |
Average diversification
The 3 months correlation between Evogene and Gamida is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding Evogene and Gamida Cell in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Gamida Cell and Evogene is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Evogene are associated (or correlated) with Gamida Cell. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Gamida Cell has no effect on the direction of Evogene i.e., Evogene and Gamida Cell go up and down completely randomly.
Pair Corralation between Evogene and Gamida Cell
If you would invest 140.00 in Gamida Cell on August 26, 2024 and sell it today you would earn a total of 0.00 from holding Gamida Cell or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 4.55% |
| Values | Daily Returns |
Evogene vs. Gamida Cell
Performance |
| Timeline |
| Evogene |
| Gamida Cell |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Evogene and Gamida Cell Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Evogene and Gamida Cell
The main advantage of trading using opposite Evogene and Gamida Cell positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Evogene position performs unexpectedly, Gamida Cell can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Gamida Cell will offset losses from the drop in Gamida Cell's long position.| Evogene vs. Eliem Therapeutics | Evogene vs. HCW Biologics | Evogene vs. Scpharmaceuticals | Evogene vs. Milestone Pharmaceuticals |
| Gamida Cell vs. BioLineRx | Gamida Cell vs. Ardelyx | Gamida Cell vs. Lexicon Pharmaceuticals | Gamida Cell vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Complementary Tools
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |